Sunshine Biopharma SBFM
NASDAQ SBFM
$0.69 -0.09 (-11.05%)
As of: Oct 1, 2026 · 3:59 PM EDT

Sunshine Biopharma (SBFM) Return on Equity [ROE] (2011 - 2026)

Updated

Sunshine Biopharma's Return on Equity [ROE] came in at -23.78% for Q2 2026, up 0.70 percentage points from -24.48% a year earlier and up 3.33 percentage points from the prior quarter.

Analysis

Sunshine Biopharma (SBFM) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Sunshine Biopharma's Return on Equity [ROE] was -25.68%, down 2.71 percentage points from FY2024.

  • Return on Equity [ROE] carries a three-year change of +219.24 percentage points (FY2022 to FY2025).
  • Going back by year, Return on Equity [ROE] was -22.97% in FY2024 (-1.93 pp), -21.04% in FY2023 (+223.88 pp) and -244.92% in FY2022.
  • The five-year range for quarterly Return on Equity [ROE] is -132.55% (Q1 2023) to -8.63% (Q3 2022).
  • Year-over-year, Return on Equity [ROE] increased in three of the last eight quarters, with an average year-over-year change of +9.27 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2024 (a gain of 114.67 percentage points), and the weakest in Q3 2023 (a drop of 110.20 percentage points).
  • Business Quant data shows SBFM's Return on Equity [ROE] at -27.11% (Q1 2026), -25.30% (Q4 2025) and -22.49% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Sunshine Biopharma 1.05 Mn -38.04 Mn 2.43 Mn -23.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.78%
Mar 31, 2026 -27.11%
Dec 31, 2025 -25.30%
Sep 30, 2025 -22.49%
Jun 30, 2025 -24.48%
Mar 31, 2025 -20.11%
Dec 31, 2024 -19.79%
Sep 30, 2024 -17.48%
Jun 30, 2024 -15.35%
Mar 31, 2024 -17.88%
Dec 31, 2023 -20.75%
Sep 30, 2023 -118.83%
Jun 30, 2023 -129.64%
Mar 31, 2023 -132.55%
Dec 31, 2022 -86.26%
Sep 30, 2022 -8.63%
Jun 30, 2022 -22.21%
Mar 31, 2022 -125.26%
Dec 31, 2016 -1,820.12%
Jun 30, 2013 -859.20%
API Access

Sunshine Biopharma Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SBFM&period=max&api_key=YOUR_API_KEY